Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Rhea-AI Summary

Invivyd (Nasdaq: IVVD) reported that on August 1, 2026, it granted stock options to ten newly hired non-executive employees to purchase an aggregate of 277,500 common shares under the 2026 Inducement Plan, as material inducement awards in accordance with Nasdaq Listing Rule 5635(c)(4).

The options have a per-share exercise price of $0.535, equal to the July 31, 2026 closing price of Invivyd’s stock. Each option vests over four years, with 25% vesting on the first anniversary of the employee’s start date and the remainder vesting in equal monthly installments, subject to continued service. The options have a 10-year term and remain subject to the plan’s terms.

Argus Aug 4 session 14 alerts

+3.92% close to close 1.6x rel. volume Open Argus

Details

News Market Reaction – IVVD

+8.6% Peak in 32 hr 9 min

$185.60M Market Cap

In the Aug 4 session, IVVD gained 3.92%, reflecting a moderate positive market reaction. Argus tracked a peak move of +8.6% during that session. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. Trading volume was above average at 1.6x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The prior inducement-grant release, news_id 1077476, recorded a 4.61% 24-hour reaction. The active S...

Analysis

The prior inducement-grant release, news_id 1077476, recorded a 4.61% 24-hour reaction. The active S-3 shelf and moderate short positioning add financing and volatility context; future award frequency and size remain observable.

Key Figures

Grant Date: August 1, 2026 Employees: 10 employees Option Shares: 277,500 shares +4 more

Grant Date

August 1, 2026

Employee option grants

Employees

10 employees

Newly hired non-executive employees

Option Shares

277,500 shares

Aggregate common stock options granted

Exercise Price

$0.535 per share

Equal to the July 31, 2026 closing price

Vesting Period

4 years

Option vesting schedule

Initial Vesting

25%

Vests on the first anniversary of the employee’s start date

Option Term

10 years

Term of each option

Historical Context

5 past events · Latest: Jul 06

5 events

1. Jul 06

   EUA termination notice

   24h Move

   -6.7%

   FDA notice set PEMGARDA EUA termination for June 29, 2027

2. Jul 02

   Inducement grants

   24h Move

   +4.6%

   Fourteen employees received options for 493,000 shares at $0.8544 each

3. Jun 16

   Enrollment completion

   24h Move

   +2.7%

   Company completed Phase 3 LIBERTY enrollment; topline data were expected in Q3 2026

4. Jun 09

   First trial dosing

   24h Move

   -2.9%

   LIBERTY dosed its first participants in a Phase 3 COVID-19 prevention trial

5. Jun 03

   Inducement grants

   24h Move

   -3.5%

   Seventeen employees received options for 513,500 shares under the 2026 Inducement Plan

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq listing rule 5635(c)(4)

1 terms

nasdaq listing rule 5635(c)(4) regulatory

"The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW HAVEN, Conn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on August 1, 2026, Invivyd granted ten newly hired non-executive employees options to purchase an aggregate of 277,500 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan. 

The options have a per share exercise price of $0.535, representing the closing price of Invivyd’s common stock on July 31, 2026, the last trading date prior to the date of grant. Each option vests over four years, with 25% of the shares subject to such option vesting on the first anniversary of the employee’s start date and the remaining shares vesting in equal monthly installments thereafter, in each case, subject to the employee’s continuous service with Invivyd. The options have a 10-year term and are subject to the terms of the Invivyd, Inc. 2026 Inducement Plan. 

About Invivyd

Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.  

This press release contains hyperlinks to information that is not deemed to be incorporated by reference in this press release. 

Contacts: 

Media Relations 
(781) 208-0160 
media@invivyd.com 

Investor Relations 
(781) 208-1747 
investors@invivyd.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock options did Invivyd (NASDAQ: IVVD) grant on August 1, 2026?

Invivyd granted options for an aggregate 277,500 common shares to ten new non-executive employees. According to Invivyd, these options were issued as material inducement awards under the 2026 Inducement Plan, consistent with Nasdaq Listing Rule 5635(c)(4).

What is the exercise price of the new Invivyd (IVVD) inducement stock options?

The new Invivyd inducement stock options have a per-share exercise price of $0.535. According to Invivyd, this price equals the closing market price of its common stock on July 31, 2026, the last trading day before the grant date.

How do the Invivyd (IVVD) August 2026 inducement options vest for new employees?

The Invivyd inducement options vest over four years, with 25% vesting on the first employment anniversary. According to Invivyd, the remaining 75% vests in equal monthly installments thereafter, subject to each employee’s continuous service with the company.

What is the term of Invivyd’s August 2026 inducement stock options (IVVD)?

Invivyd’s August 2026 inducement stock options have a 10-year term from the grant date. According to Invivyd, the options remain subject to all provisions of the Invivyd 2026 Inducement Plan throughout this term.

Under which plan were the Invivyd (IVVD) August 2026 inducement options granted?

The August 2026 inducement options were granted under the Invivyd 2026 Inducement Plan. According to Invivyd, these awards were specifically structured to comply with Nasdaq Listing Rule 5635(c)(4) for material inducement grants to newly hired employees.